Clinical Trial

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

Name: Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma — clinical trial record (NCT06987916)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is an open-label phase1 study to assess the safety and efficacy of U01(ssCART-19) cell therapy in the treatment of patients with refractory or recurrent B-cell lymphoma .

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-05-15; most recent amendment 2025-05-31.

Trial Details

NCT Number	NCT06987916
Lead Sponsor	Shanghai Tongji Hospital, Tongji University School of Medicine
Conditions	B Cell Lymphoma
Enrollment	50 participants
Start Date	2025-04-22
Primary Completion	2028-04-22 (estimated)
Study Completion	2030-04-22 (estimated)
Updated on ClinicalTrials.gov	2025-06-05